Trial Information

Summary: Study to Investigate the Safety of FCM vs Standard Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients

The Billings Clinic Research Center is currently enrolling women who have Iron Deficiency Anemia as the result of being a post partum patient or due to heavy uterine bleeding within the past six months. The study is investigating the safety and tolerability of an investigational iron medication versus Standard of Care for the treatment of Iron Deficiency Anemia. Office visits, physical examinations, diagnostic tests and study medication are provided at no charge. Length of the study is 5-6 weeks. Compensation may also be available for visits completed.

Patient Inclusion Criteria
Females with Iron Deficiency Anemia

Patient Exclusion Criteria
History of Anemia other than Anemia due to heavy uterine bleeding or post partum state. Current history of GI bleeding. Malignancy history. Received IV iron within the last 3 months. Pregnant or sexually active females who are not willing to use an effective form of birth control. Known hypersensitivity to FCM.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.